# Noopept

> Dipeptide-derived nootropic researched for memory and neuroprotection.

Source: https://peptides.cafe/peptide/noopept
Category: Nootropic · Neuroprotection
Tag: Cognition

## Mechanism
A synthetic dipeptide (N-phenylacetyl-L-prolylglycine ethyl ester) derived from the endogenous nootropic cycloprolylglycine. Research suggests it potentiates AMPA receptor activity, increases BDNF and NGF expression, and provides antioxidant protection in neuronal tissue.

## Research areas
- Memory consolidation and retrieval
- Neuroprotection in ischemic injury
- Anxiety and emotional modulation
- Age-related cognitive decline

## Common research protocols
- Oral research dosing: Daily oral administration in Russian clinical studies for cognitive support.

## Study summaries
- "Noopept neuroprotective effects in cerebral ischemia" — Bulletin of Experimental Biology and Medicine (2009): Demonstrated protective effects against glutamate neurotoxicity in vitro.
- "Noopept in mild cognitive impairment" — Advances in Gerontology (2012): Improved cognitive scores in elderly patients with mild cognitive disorders.

## Considerations
- Approved in Russia; not FDA-approved in the US.
- Generally well tolerated with few reported side effects.

## Disclaimer
Educational content only. Not medical advice, diagnosis, or treatment. Most research peptides are not FDA-approved for human therapeutic use. Consult a licensed clinician before any use.